Veraflo Therapy had a significant effect on clinical outcomes when compared to standard of care including 3M™ V.A.C.® Therapy.
(9.88 days vs 21.8 days, p=0.02)1,2
Veraflo Therapy prepared wounds for closure faster than standard of care including 3M™ V.A.C.® Therapy in various wound types.
(7.88 days vs 14.36 days, p=0.003)1,2
(1.77 debridements vs 2.69, p=0.008)1,2
1. Gabriel A, Camardo M, O’Rorke E, Gold R, Kim PJ. Effects of Negative-Pressure Wound Therapy With Instillation versus Standard of Care in Multiple Wound Types: Systematic Literature Review and Meta-Analysis. Plast Reconstr Surg. 2021 Jan 1;147(1S-1):68S-76S. doi: 10.1097/PRS.0000000000007614. PMID: 33347065.
2. Camardo, Mark. “Veraflo Meta-Analysis Standardized and Non-Standardized Means.”, 3M Internal Report, San Antonio, Texas, 2020
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.
3M and the other marks shown are marks and/or registered marks. Unauthorized use prohibited. PRA-PM-US-03006 (03/21)
See results of a recently published meta-analysis of 13 studies and 720 patients.
The brands listed above are trademarks of 3M.